Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes and tumor vasculature represent broad physiological compartments rather than specific molecular targets. The tumor vasculature consists of the irregular, leaky blood vessels that supply oxygen and nutrients to a growing tumor, while cellular membranes are the lipid bilayers that define the boundaries of all cells. In oncology, these structures are targeted by various therapeutic strategies, including vascular disrupting agents (VDAs) that collapse existing tumor vessels and photodynamic therapies that generate reactive oxygen species to damage membranes and endothelial linings. Because this term encompasses a wide array of proteins, lipids, and cell types, it is generally considered a therapeutic site or microenvironmental component rather than a single druggable receptor or enzyme.
Drugs targeting these structures typically act via vascular disruption, induction of oxidative stress through photodynamic therapy, or physical disruption of membrane integrity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes and tumor vasculature.